|
|
.
See Category: Neoplasms
See Header: Malignant neoplasm of lower-inner quadrant of breast, female
ICD-10 (CM) Code and Descriptor
|
C50.311 |
Malignant neoplasm of lower-inner quadrant of right female breast
Diagnosis Valid for Female Patient Only
|
C50311 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 62.06%
|
24.90%
|
6.20%
|
2.57%
|
1.51%
|
0.93%
|
0.54%
|
0.35%
|
0.28%
|
0.16%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C50.311*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
9,215
|
9,264
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
6,269
|
6,272
|
|
80053
|
COMPREHEN METABOLIC PANEL |
6,217
|
6,218
|
|
77412
|
RADIATION TX DELIVERY COMPLX |
5,499
|
5,504
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
5,253
|
5,264
|
|
86300
|
IMMUNOASSAY TUMOR CA 15-3 |
1,995
|
2,139
|
|
88307
|
TISSUE EXAM BY PATHOLOGIST |
1,903
|
4,146
|
|
G0279
|
TOMOSYNTHESIS, MAMMO |
1,617
|
1,617
|
|
J3010
|
FENTANYL CITRATE INJECTION |
1,558
|
2,695
|
|
J2405
|
ONDANSETRON HCL INJECTION |
1,505
|
7,761
|
|
77387
|
GUIDANCE FOR RADJ TX DLVR |
1,496
|
1,526
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
1,461
|
11,700
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
1,399
|
45,166
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
1,343
|
2,245
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
1,319
|
5,179
|
|
77065
|
DX MAMMO INCL CAD UNI |
1,275
|
1,281
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
1,243
|
1,844
|
|
77066
|
DX MAMMO INCL CAD BI |
1,219
|
1,219
|
|
77336
|
RADIATION PHYSICS CONSULT |
1,164
|
1,165
|
|
19301
|
PARTIAL MASTECTOMY |
1,063
|
1,063
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C50.311 related to the following DRG Codes:
582-583
597-599
|
